Flag Ship Acquisition (ETHZ) Competitors $2.47 +0.03 (+1.23%) As of 09/10/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock ETHZ vs. KPTI, ALXO, PDSB, COEP, ZIVO, BTAI, CELU, QNTM, BRNS, and NRXPShould you be buying Flag Ship Acquisition stock or one of its competitors? The main competitors of Flag Ship Acquisition include Karyopharm Therapeutics (KPTI), ALX Oncology (ALXO), PDS Biotechnology (PDSB), Coeptis Therapeutics (COEP), ZIVO Bioscience (ZIVO), BioXcel Therapeutics (BTAI), Celularity (CELU), Quantum Biopharma (QNTM), Barinthus Biotherapeutics (BRNS), and NRx Pharmaceuticals (NRXP). These companies are all part of the "pharmaceutical products" industry. Flag Ship Acquisition vs. Its Competitors Karyopharm Therapeutics ALX Oncology PDS Biotechnology Coeptis Therapeutics ZIVO Bioscience BioXcel Therapeutics Celularity Quantum Biopharma Barinthus Biotherapeutics NRx Pharmaceuticals Flag Ship Acquisition (NASDAQ:ETHZ) and Karyopharm Therapeutics (NASDAQ:KPTI) are both small-cap pharmaceutical products companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk. Do analysts rate ETHZ or KPTI? Karyopharm Therapeutics has a consensus target price of $34.00, indicating a potential upside of 447.50%. Given Karyopharm Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Karyopharm Therapeutics is more favorable than Flag Ship Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Flag Ship Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Karyopharm Therapeutics 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Which has more volatility and risk, ETHZ or KPTI? Flag Ship Acquisition has a beta of 0.37, meaning that its stock price is 63% less volatile than the S&P 500. Comparatively, Karyopharm Therapeutics has a beta of 0.35, meaning that its stock price is 65% less volatile than the S&P 500. Is ETHZ or KPTI more profitable? Flag Ship Acquisition has a net margin of 0.00% compared to Karyopharm Therapeutics' net margin of -90.02%. Karyopharm Therapeutics' return on equity of 0.00% beat Flag Ship Acquisition's return on equity.Company Net Margins Return on Equity Return on Assets Flag Ship AcquisitionN/A -141.25% -80.77% Karyopharm Therapeutics -90.02%N/A -84.28% Does the media refer more to ETHZ or KPTI? In the previous week, Karyopharm Therapeutics had 5 more articles in the media than Flag Ship Acquisition. MarketBeat recorded 8 mentions for Karyopharm Therapeutics and 3 mentions for Flag Ship Acquisition. Karyopharm Therapeutics' average media sentiment score of 0.87 beat Flag Ship Acquisition's score of 0.00 indicating that Karyopharm Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Flag Ship Acquisition 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Karyopharm Therapeutics 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, ETHZ or KPTI? Flag Ship Acquisition has higher earnings, but lower revenue than Karyopharm Therapeutics. Karyopharm Therapeutics is trading at a lower price-to-earnings ratio than Flag Ship Acquisition, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFlag Ship AcquisitionN/AN/A-$6.17M-$15.07-0.16Karyopharm Therapeutics$145.24M0.37-$76.42M-$14.59-0.43 Do insiders & institutionals believe in ETHZ or KPTI? 4.1% of Flag Ship Acquisition shares are owned by institutional investors. Comparatively, 66.4% of Karyopharm Therapeutics shares are owned by institutional investors. 38.2% of Flag Ship Acquisition shares are owned by insiders. Comparatively, 3.0% of Karyopharm Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryKaryopharm Therapeutics beats Flag Ship Acquisition on 9 of the 14 factors compared between the two stocks. Get Flag Ship Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for ETHZ and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ETHZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ETHZ vs. The Competition Export to ExcelMetricFlag Ship AcquisitionPharmaceutical Preparations IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$14.74M$876.45M$2.54B$10.07BDividend YieldN/A4.84%2.50%4.53%P/E RatioN/A1.1126.1826.01Price / SalesN/A26.51118.74117.75Price / CashN/A19.5623.0759.95Price / Book0.856.7731.596.20Net Income-$6.17M-$4.20M$16.40M$270.65M7 Day Performance2.07%0.96%1.11%2.84%1 Month PerformanceN/A8.68%4.17%7.23%1 Year PerformanceN/A22.25%32.76%26.49% Flag Ship Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ETHZFlag Ship AcquisitionN/A$2.47+1.2%N/AN/A$14.74MN/A0.007Options VolumeGap DownKPTIKaryopharm Therapeutics3.8964 of 5 stars$6.60-2.1%$34.00+415.2%-42.9%$58.40M$145.24M-0.45380News CoverageALXOALX Oncology4.0958 of 5 stars$1.22+13.0%$3.30+170.5%-45.8%$57.83MN/A-0.5540Positive NewsGap DownPDSBPDS Biotechnology1.8634 of 5 stars$1.20-1.6%$10.00+733.3%-59.1%$57.37MN/A-1.3020COEPCoeptis Therapeutics1.465 of 5 stars$12.27+3.2%N/A+251.8%$57.29MN/A-2.122News CoverageShort Interest ↓Gap UpZIVOZIVO Bioscience0.1679 of 5 stars$14.85-1.0%N/A+16.9%$57.26M$15.85K-3.0410News CoverageGap UpBTAIBioXcel Therapeutics4.1024 of 5 stars$3.79+6.2%$39.75+948.8%-59.3%$57.15M$2.27M-0.3090CELUCelularity1.8903 of 5 stars$2.41+2.1%$6.00+149.0%-11.0%$56.52M$54.22M-0.76220News CoverageAnalyst UpgradeQNTMQuantum BiopharmaN/A$14.06-1.6%N/A+323.3%$54.53MN/A-1.00N/ANews CoverageGap UpBRNSBarinthus Biotherapeutics2.6192 of 5 stars$1.24-6.8%$3.00+141.9%-11.3%$54.15M$14.97M-0.72107NRXPNRx Pharmaceuticals3.4346 of 5 stars$2.75+4.6%$28.50+936.4%+70.7%$52.10MN/A-1.232Trending NewsAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies Karyopharm Therapeutics Competitors ALX Oncology Competitors PDS Biotechnology Competitors Coeptis Therapeutics Competitors ZIVO Bioscience Competitors BioXcel Therapeutics Competitors Celularity Competitors Quantum Biopharma Competitors Barinthus Biotherapeutics Competitors NRx Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ETHZ) was last updated on 9/11/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Flag Ship Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Flag Ship Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ETHZ Stock Alerts